EGFR and breast cancer: In contrast, the intrinsic induction of PD-L1 on the surface of tumor cells is mediated by constitutive oncogenic and transcriptional pathways, such as the PI3K and mTOR pathways in non-small cell lung cancer and the EGFR-MAP kinase pathway in breast cancer [29].